Flex UI, a new software interface for computed radiography products made by Fujifilm Medical Systems USA, enables users to define functionality according to departmental protocol. The interface can run on a range of platforms, including PDAs and tablet
Flex UI, a new software interface for computed radiography products made by Fujifilm Medical Systems USA, enables users to define functionality according to departmental protocol. The interface can run on a range of platforms, including PDAs and tablet PCs. Flex UI is designed to enhance workflow by accommodating individual preferences. It builds on the earlier development of Fuji's Flash IIP console, which automates the patient registration process. Flex UI further simplifies the process using customizable protocols and providing quicker access to frequently used functions through icons representing these functions. Patient information fields can also be customized.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 3rd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 3rd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 3rd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.